VASC Financial Facts

Research and development: 4.07M
Cost of goods sold: 11.3M
See Full Income Statement

Total shareholders' equity: 114.81M
Additional paid-in capital: 97.29M
See Full Balance Sheet

Vascular Solutions (VASC) Earnings

  |   Expand Research on VASC
Next EPS Date 7/21/15 EPS Growth Rate +25.0%
Average EPS % Beat Rate +7.6% Revenue Growth Rate +15.9%
Average % Move 1-Wk after EPS +6.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/21/15 Q215 N/A$0.25 N/A N/A$35.59M N/A N/A
4/21/15 Q115 $0.21$0.18 +$0.03$34.6M$33.38M Details
2/3/15 Q414 $0.23$0.18 +$0.05$33.6M$32.82M Details
10/21/14 Q314 $0.15$0.20 -$0.05$31.9M$31.1M = Details
7/22/14 Q214 $0.20$0.18 +$0.02$30.7M$30.43M Details
4/22/14 Q114 $0.16N/A N/A $29.9M$26.1M Details
2/4/14 Q413 $0.22$0.19 +$0.03$29.1M$28.61M Details
10/22/13 Q313 $0.19$0.07 +$0.12$28M$27.1M = Details